-+ 0.00%
-+ 0.00%
-+ 0.00%
Beacon Therapeutics named to Fierce Biotech’s 2026 Fierce 15 list
Share
Listen to the news
Beacon Therapeutics named to Fierce Biotech’s 2026 Fierce 15 list
  • Beacon Therapeutics was named to Fierce Biotech’s 2026 “Fierce 15” list of private biotechnology companies.
  • Recognition follows positive topline results from Beacon’s pivotal trial of laru-zova in X-linked retinitis pigmentosa.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Forbion Capital Partners Management Services BV published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending